Patents Assigned to Novocure, Inc.
  • Methods and compositions that control lipid production
    Patent number: 6673623
    Abstract: The present invention relates generally to the use of lipogenins, proteins, e.g. human extra-cellular matrix protein 1 (ECM-1), human glia-derived nexin I alpha protein (NP-I), human tissue inhibitor of metalloproteinase-2 (TIMP-2) and human histone H2A (H2A) singly or in various combinations to control lipogenesis in a mammal.
    Type: Grant
    Filed: September 12, 2000
    Date of Patent: January 6, 2004
    Assignee: Novocure, Inc.
    Inventor: Eliezer Huberman